Jennison Associates LLC reduced its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 27.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 91,700 shares of the health services provider's stock after selling 35,318 shares during the quarter. Jennison Associates LLC owned approximately 0.05% of Teladoc Health worth $730,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Proficio Capital Partners LLC bought a new position in Teladoc Health during the fourth quarter worth $510,000. PNC Financial Services Group Inc. boosted its holdings in shares of Teladoc Health by 22.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider's stock valued at $73,000 after buying an additional 1,439 shares during the period. Swiss National Bank grew its position in shares of Teladoc Health by 1.1% during the 4th quarter. Swiss National Bank now owns 336,702 shares of the health services provider's stock valued at $3,061,000 after buying an additional 3,600 shares during the last quarter. Commonwealth Equity Services LLC raised its stake in Teladoc Health by 35.7% during the fourth quarter. Commonwealth Equity Services LLC now owns 113,563 shares of the health services provider's stock worth $1,032,000 after acquiring an additional 29,903 shares during the period. Finally, Cibc World Markets Corp bought a new position in Teladoc Health in the fourth quarter worth about $146,000. Institutional investors own 76.82% of the company's stock.
Teladoc Health Price Performance
Shares of TDOC traded up $0.11 during mid-day trading on Tuesday, hitting $8.44. The company's stock had a trading volume of 7,269,605 shares, compared to its average volume of 6,397,407. Teladoc Health, Inc. has a one year low of $6.35 and a one year high of $15.21. The stock's 50-day moving average is $7.57 and its two-hundred day moving average is $8.62. The company has a quick ratio of 1.64, a current ratio of 1.68 and a debt-to-equity ratio of 0.70.
Insider Activity at Teladoc Health
In other Teladoc Health news, insider Carlos Nueno sold 3,958 shares of the firm's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $27,151.88. Following the completion of the transaction, the insider owned 17,645 shares in the company, valued at $121,044.70. This trade represents a 18.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Adam C. Vandervoort sold 5,808 shares of Teladoc Health stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $39,842.88. Following the completion of the transaction, the insider owned 69,773 shares of the company's stock, valued at $478,642.78. This trade represents a 7.68% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 18,656 shares of company stock worth $128,189. Company insiders own 0.58% of the company's stock.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the stock. Evercore ISI boosted their price target on shares of Teladoc Health from $7.00 to $8.00 and gave the company an "in-line" rating in a report on Wednesday, July 9th. Stifel Nicolaus lowered their price target on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a report on Thursday, May 1st. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Truist Financial lowered their target price on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research note on Tuesday, May 27th. Finally, Bank of America reduced their price target on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a research note on Wednesday, May 28th. Twelve equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $9.65.
View Our Latest Stock Analysis on TDOC
About Teladoc Health
(
Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
